Smith Drugs Llc
Community/Retail Pharmacy
108 Rowe St, Dublin
Georgia, 31021-5238
478-272-7722 478-272-7722
Smith Drugs Llc is an authorized DME supplier for medicare equipments and products.
Smith Drugs Llc is a Community/Retail Pharmacy in Dublin, Georgia. It is located at 108 Rowe St, Dublin and it's customer support contact number is 478-272-7722. The authorized person of Smith Drugs Llc is Wendell Smith who is Owner of the pharmacy and his contact number is 478-272-8065. Active license number of Smith Drugs Llc is PHRE005857 for Community/Retail Pharmacy in Georgia. Smith Drugs Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Smith Drugs Llc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Smith Drugs Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Smith Drugs Llc |
| Type: | Community/Retail Pharmacy |
| Location: | 108 Rowe St, Dublin, Georgia, 31021-5238 |
| Phone: | 478-272-7722 |
| Fax: | 478-272-7722 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Wendell Smith |
| Position: | Owner |
| Contact Number: | 478-272-8065 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1245337088 |
| NPI Enumeration Date: | 20 Sep, 2006 |
| NPI Last Update On: | 23 Dec, 2015 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Smith Drugs Llc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | PHRE005857 | Georgia | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2012332 | Other | | Pk |
| 00034999A | Medicaid | Georgia | |
Medicare Enrollment:
Smith Drugs Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 1153528286 | O20100930041636 | Smith Drugs Llc | DME SUPPLIER - PHARMACY |
Products Available:
Smith Drugs Llc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 108 Rowe St, Dublin, Georgia |
| Zip: | 31021-5238 |
| Phone Number: | 478-272-7722 |
| Fax Number: | 478-272-7776 |
Patients can reach Smith Drugs Llc at
108 Rowe St, Dublin, Georgia or can
call on customer care at 478-272-7722.
Comments/ Reviews:
Read all the reviews posted for Smith Drugs Llc below. You may also share your own experience with Smith Drugs Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.